NewEdge Wealth LLC Buys New Position in The Allstate Corporation $ALL

NewEdge Wealth LLC purchased a new stake in The Allstate Corporation (NYSE:ALL) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 3,235 shares of the insurance provider’s stock, valued at approximately $770,000.

A number of other hedge funds and other institutional investors have also modified their holdings of ALL. MV Capital Management Inc. acquired a new position in shares of Allstate in the 4th quarter valued at $25,000. Gables Capital Management Inc. purchased a new stake in Allstate in the second quarter valued at approximately $26,000. Navalign LLC purchased a new position in shares of Allstate during the fourth quarter worth approximately $27,000. Kelleher Financial Advisors acquired a new stake in Allstate during the 2nd quarter worth $28,000. Finally, Evolution Wealth Management Inc. boosted its stake in shares of Allstate by 7,000.0% during the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock worth $29,000 after buying an additional 140 shares during the period. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, COO Mario Rizzo sold 56,225 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the sale, the chief operating officer owned 82,227 shares in the company, valued at $21,747,396.96. This trade represents a 40.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider John E. Dugenske sold 32,996 shares of Allstate stock in a transaction on Friday, August 7th. The shares were sold at an average price of $269.33, for a total value of $8,886,812.68. Following the completion of the sale, the insider directly owned 13,054 shares of the company’s stock, valued at approximately $3,515,833.82. This represents a 71.65% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 91,446 shares of company stock valued at $24,208,675. Company insiders own 1.55% of the company’s stock.

More Allstate News

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Allstate Price Performance

NYSE:ALL opened at $253.82 on Friday. The firm has a market cap of $64.18 billion, a price-to-earnings ratio of 5.07, a price-to-earnings-growth ratio of 0.39 and a beta of 0.16. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24. The company’s 50-day moving average is $250.34 and its two-hundred day moving average is $224.95. The Allstate Corporation has a 12-month low of $188.08 and a 12-month high of $277.22.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, topping analysts’ consensus estimates of $6.06 by $2.93. The business had revenue of $18.60 billion during the quarter, compared to the consensus estimate of $15.46 billion. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The company’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.94 earnings per share. Research analysts expect that The Allstate Corporation will post 34.45 EPS for the current year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be paid a $1.08 dividend. This represents a $4.32 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Monday, August 31st. Allstate’s payout ratio is presently 8.63%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on ALL shares. JPMorgan Chase & Co. lifted their price objective on shares of Allstate from $282.00 to $292.00 and gave the company an “overweight” rating in a research report on Tuesday, August 11th. The Goldman Sachs Group restated a “neutral” rating and issued a $280.00 price objective on shares of Allstate in a research report on Friday, August 7th. Mizuho increased their target price on Allstate from $255.00 to $272.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Evercore set a $240.00 price target on Allstate in a research note on Friday, July 10th. Finally, Citigroup downgraded Allstate from a “neutral” rating to a “sell” rating and raised their target price for the company from $226.00 to $240.00 in a report on Tuesday, August 11th. Four investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $265.26.

Allstate Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.